JSC “Kalceks” launches Atracurium besilate solution for injection
JSC “Kalceks” starts commercialization of Atracurium besilate 10 mg/ml 2.5 ml and 5 ml solution for injection. Product has been approved via decentralized registration procedure involving 14 European Union countries.
Medicinal product contains active ingredient Atracurium besilate and it is used as an adjunct to general anaesthesia to facilitate tracheal intubation, to relax skeletal muscles during surgery or controlled ventilation, and to facilitate mechanical ventilation of patients in the intensive care unit
This is second product that Kalceks launches by this year and also it is a product that is registered in parallel way in so far maximal for Kalceks count of countries.